quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:11:46·583d
SECFiling
Talis Biomedical Corporation logo

Talis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

TLIS· Talis Biomedical Corporation
Industrials
Original source

Companies

  • TLIS
    Talis Biomedical Corporation
    Industrials

Recent analyst ratings

  • Jan 7UpdateBofA Securities$3.00
  • Sep 27UpdateJP Morgan$7.00
  • Aug 31UpdateBTIG Research-
  • Aug 12UpdatePiper Sandler$9.00
  • Aug 11UpdateJP Morgan$10.00

Related

  • 13D/G560d
    Amendment: SEC Form SC 13D/A filed by Talis Biomedical Corporation
  • SEC571d
    SEC Form 15-12G filed by Talis Biomedical Corporation
  • SEC581d
    SEC Form 25-NSE filed by Talis Biomedical Corporation
  • SEC591d
    SEC Form S-8 POS filed by Talis Biomedical Corporation
  • SEC591d
    SEC Form S-8 POS filed by Talis Biomedical Corporation
  • SEC591d
    SEC Form S-8 POS filed by Talis Biomedical Corporation
  • SEC591d
    SEC Form S-8 POS filed by Talis Biomedical Corporation
  • INSIDER591d
    Large owner Leonard Braden Michael bought $44,240 worth of shares (30,100 units at $1.47) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022